Copyright
©The Author(s) 2016.
World J Transplant. Mar 24, 2016; 6(1): 165-173
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.165
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.165
Parameter | 2 points | 1 point | 0 points |
Thrombocytopenia | Platelet count drop > 50% and platelet nadir ≥ 20 g/L | Platelet count drop 30%-50% or platelet nadir 10-19 g/L | Platelet count drop < 30% or platelet nadir < 10 g/L |
Timing of platelet count drop | Onset on days 5-10 or platelet count drop ≤ 1 d and previous heparin exposure < 30 d ago | Onset on days 5-10 but platelet count drop not clear (e.g., missing counts); onset after day 10 of heparin therapy or drop ≤ 1 d and previous heparin exposure 30-100 d ago | Platelet count drop ≤ 4 d after beginning of heparin therapy and no previous heparin exposure |
Thrombosis and sequelae | New proven thrombosis; skin necrosis; acute systemic reaction after heparin application | Progressive or recurrent thrombosis; suspected thrombosis; non-necrotizing skin lesions | None |
Other causes of thrombocytopenia | Apparently none | Possible | Definite |
- Citation: Assfalg V, Hüser N. Heparin-induced thrombocytopenia in solid organ transplant recipients: The current scientific knowledge. World J Transplant 2016; 6(1): 165-173
- URL: https://www.wjgnet.com/2220-3230/full/v6/i1/165.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i1.165